Indole derivatives useful as progesterone receptor modulators

Details for Australian Patent Application No. 2005302706 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Sui, Zhihua; Jiang, Weiqin; Fiordeliso, James J.

Agent Shelston IP

Pub. Number AU-B-2005302706

PCT Pub. Number WO2006/049889

Priority 60/622,582 27.10.04 US

Filing date 21 October 2005

Wipo publication date 11 May 2006

Acceptance publication date 15 December 2011

International Classifications

C07D 209/30 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/404 (2006.01)

A61P 5/24 (2006.01) Drugs for disorders of the endocrine system

A61P 15/18 (2006.01) Drugs for genital or sexual disorders

Event Publications

17 May 2007 PCT application entered the National Phase

  PCT publication WO2006/049889 Priority application(s): WO2006/049889

15 December 2011 Application Accepted

  Published as AU-B-2005302706

12 April 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005302707-Pyridine imidazoles and aza-indoles as progesterone receptor modulators

2005302697-Tetrahydro pyridinyl pyrazole cannabinoid modulators